Self-developed and patented innovations in m-health

Brighter

Brighter AB is a Swedish company that develops medical devices to treat diseases with a high unmet need. Its lead product in development is Actiste, for diabetes management.

Financials

Brighter

SEKm 2017 2018 2019
Sales 1 0 4
Sales growth (%) -58,3 -100 0
EBITDA -50 -70 -72
EBITDA margin (%) -3609,3 0 -1621,9
EBIT adj -50 -74 -83
EBIT adj margin (%) -3609,3 0 -1873,3
Pretax profit -57 -76 -84
EPS rep -1,33 -1,48 -1,76
EPS growth (%) -17,7 -11,5 -18,8
EPS adj -1,33 -1,48 -1,76
DPS 0 0 0
EV/EBITDA (x) -13 -9,7 -7,6
EV/EBIT adj (x) -13 -9,1 -6,5
P/E (x) -7,6 -7,2 -6,1
P/E adj (x) -7,6 -7,2 -6,1
EV/sales (x) 470,5 0 122,6
FCF yield (%) -11,4 -12,9 -9,9
Dividend yield (%) 0 0 0
Net IB debt/EBITDA 0 0,3 2,1

Main shareholders

Brighter

Main shareholders Share capital % Voting shares % Verified
Avanza Pension 13.5 % 13.5 % 30 Sep 2018
Truls Sjöstedt 8.9 % 8.9 % 9 Jul 2018
Michael Göran Erik Frantzén 7.1 % 7.1 % 31 Mar 2017
Jonas Metzger 1.6 % 1.6 % 30 Sep 2018
Minh Nguyen 1.4 % 1.4 % 30 Sep 2018
Robert Mellin 1.3 % 1.3 % 30 Sep 2018
Swedbank Försäkring 1.2 % 1.2 % 30 Sep 2018
Nordnet Pensionsförsäkring 1.2 % 1.2 % 30 Sep 2018
Henrik Norström 0.9 % 0.9 % 11 Oct 2018
Livförsäkringsbolaget Skandia 0.9 % 0.9 % 30 Sep 2018

Insider list

Brighter

Name
Henrik Norström
Henrik Norström
Henrik Norström
Henrik Norström
Henrik Norström
Truls Sjöstedt
Truls Sjöstedt
Henrik Norström
Henrik Norström
Jan Stålemark
Show More